Markets

Lumenis prices IPO at $12, well below the range

Lumenis, which sells laser-based systems used in surgical, ophthalmic and aesthetic procedures, raised $75 million by offering 6.3 million shares at $12, well below the range of $15 to $17. Lumenis will list on the NASDAQ under the symbol LMNS. Goldman Sachs, Credit Suisse and Jefferies acted as joint bookrunners on the deal.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Other Topics

IPOs